People who score high on the neuroticism personality trait are at increased risk of developing dementia later in life, and recent research points to an imbalance in circulating fatty acids as a potential explanation. A large study of middle-aged adults suggests that neuroticism is associated with lower blood levels of omega-3 fatty acids, which in turn is associated with a higher likelihood of brain vascular damage and cognitive decline. The study results were published in the Journal of Affective Disorders.
Neuroticism is a basic personality trait that describes a person’s tendency to experience negative emotions such as anxiety, worry, and irritability in response to stress. Health researchers have consistently linked high levels of this trait to a variety of physical and mental health challenges. Over the past decade, observational evidence has emerged showing that levels of neuroticism increase the likelihood of developing dementia.
The biological pathways linking personality traits and degenerative brain conditions remain poorly understood. Experts suspect an indirect pathway to cardiovascular health. Neuroticism is known to be correlated with negative lifestyle choices that gradually worsen heart health over a lifetime. Notably, high neuroticism is more strongly associated with vascular dementia, which results from decreased blood flow to the brain, than with Alzheimer’s disease.
To investigate the molecular link between personality and cognitive decline, researchers focused on metabolites. These are small molecules produced when the body breaks down food, drugs, or its own tissues. Because metabolites are the final downstream products of biological processes, they provide a snapshot of both genetic and environmental influences on a person’s physical condition.
Yaqing Gao, a researcher at the University of Oxford, led a team investigating whether specific metabolic profiles could explain the link between personality and dementia. Researchers wanted to systematically screen hundreds of blood markers to see which ones tracked anxious personality traits. From there, they aimed to determine whether the same chemical signature would predict a future dementia diagnosis.
Researchers conducted a large-scale study using data from the UK Biobank, based on information from 215,624 participants aged 40 to 69. At the beginning of the data collection period, participants were assessed for neuroticism using a standard psychological questionnaire and provided a blood sample.
Nuclear magnetic resonance spectroscopy is an advanced biochemical method that uses magnetic fields to identify specific types of molecules. The researchers applied this technique to quantify 249 different metabolites in blood samples. The researchers then followed the participants for a median of about 14 years to see who developed dementia.
The analysis revealed that approximately half of the metabolites evaluated were associated with neuroticism. The most prominent pattern involved circulating fat. People with higher neuroticism scores tended to have less high-density lipoprotein and lower levels of omega-3 fatty acids. At the same time, these people showed increased levels of very low-density lipoproteins, triglycerides, and omega-6 fatty acids.
Omega-3 fatty acids, commonly found in fatty fish, are widely thought to be beneficial for cardiovascular health. Omega-6 fatty acids, often obtained from vegetable oils, are also necessary for human function, but when the number of omega-6 fatty acids in the body is much higher than omega-3 fatty acids, they can promote inflammation. Researchers have found that the balance between these two types of fats is an important predictor of future health outcomes.
Biologically, omega-3 and omega-6 fatty acids compete for the same enzymes in the human body. Omega-3 has protective properties for blood vessels, while derivatives of omega-6 fatty acids can promote blood vessel constriction and the production of inflammatory molecules. When a person consumes large amounts of omega-6 compared to omega-3, the beneficial cardiovascular effects of the latter are easily negated. The resulting inflammatory environment can gradually compromise the structural integrity of the small blood vessels that supply the brain.
Only a handful of metabolites showed consistent directional relationships with both neuroticism and dementia risk. Specifically, four markers related to omega-3 levels, including docosahexaenoic acid, were associated with lower neuroticism and lower risk of dementia. Conversely, a high ratio of omega-6 to omega-3 is associated with increased neuroticism and increased risk of dementia.
When the research team focused on specific disease subtypes, they found that omega-3 deficiency was more strongly associated with vascular dementia than with Alzheimer’s disease. The researchers also examined a smaller subset of participants who underwent brain scans. They evaluated scans for high signal intensity in the white matter, patches on the brain that indicate damage to small blood vessels. Higher levels of omega-3 corresponded to fewer spots of vascular damage on images.
To better understand whether one factor actually causes another, the team employed an analytical technique known as Mendelian randomization. This method uses natural genetic variation as a proxy for a particular trait to eliminate extraneous variables that confound observational studies. Genetic analysis suggests that neurosis causes decreased omega-3 levels. The results also suggested that decreased levels of omega-3 docosahexaenoic acid directly caused increased white matter damage in the brain.
These metabolic signatures suggest that the association between advanced neuropathy and dementia may be caused by inappropriate dietary habits. Humans cannot produce sufficient amounts of omega-3 or omega-6 fatty acids on their own, so their abundance is completely dependent on dietary intake. People who are prone to ongoing stress and anxiety may be drawn to diets that are low in fish and high in vegetable oils, ultimately depriving the circulatory system of protective nutrients. This nutritional deficiency can gradually damage blood vessels in the brain over decades.
The findings of this study have several limitations. The metabolic screening platform used in this study relies heavily on lipoproteins and misses other potentially relevant chemicals. Identifying dementia cases from hospitalization and death records can also lead to misclassification, as milder cases can easily slip through official documentation. Because the genetic tools used to assess vascular dementia are still relatively weak, inferences of causation must be treated as supportive rather than conclusive evidence.
Additionally, UK Biobank participants tend to be healthier and from higher socio-economic backgrounds than the general population. This demographic bias may affect the broad applicability of the results. Observational data remain vulnerable to residual confounding, where unmeasured factors influence both biology and behavior simultaneously. The fact that neuroticism and metabolite levels were measured simultaneously in the main analysis does not allow researchers to determine precisely how the variables affect each other sequentially.
Future research will require detailed dietary assessments to examine precisely how dietary habits govern the relationship between anxiety traits and circulating fat. Research using broader metabolic screening tools may also uncover alternative biological pathways. If future trials confirm that these causal chains exist, medical professionals may recommend dietary modifications or fish oil supplements to offset the risk of dementia associated with a highly neurotic personality.
The study, “Neurosis, omega-3 fatty acids, and the risk of developing dementia,” was authored by Yaqing Gao, Cornelia van Duijn, Thomas J. Littlejohns, and Najaf Amin.
